Key Points
- Omada Health CAO Craig Gracey sold 637 shares on July 1 at an average price of $23.00, bringing in about $14,651. After the sale, he still held 15,441 shares valued at roughly $355,143.
- Gracey has been actively selling shares recently, including multiple larger sales in late June and mid-June, indicating a steady reduction in his ownership stake.
- Omada Health shares were down 1.0% and opened at $22.39, while analysts currently rate the stock a “Moderate Buy” with an average price target of $22.91.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CAO Craig Gracey sold 637 shares of Omada Health stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $23.00, for a total transaction of $14,651.00. Following the sale, the chief accounting officer owned 15,441 shares in the company, valued at approximately $355,143. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Craig Gracey also recently made the following trade(s):
- On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total value of $8,910.00.
- On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00.
- On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The stock was sold at an average price of $20.00, for a total transaction of $41,680.00.
- On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total value of $39,597.83.
- On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total transaction of $37,494.00.
- On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.
Omada Health Trading Down 1.0%
Shares of OMDA stock opened at $22.39 on Friday. The firm has a fifty day simple moving average of $17.16 and a two-hundred day simple moving average of $15.03. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The firm has a market capitalization of $1.33 billion and a PE ratio of -82.93.
Omada Health (NASDAQ:OMDA - Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, equities analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. Perceptive Advisors LLC bought a new position in Omada Health during the 2nd quarter valued at approximately $44,402,000. Millennium Management LLC increased its stake in shares of Omada Health by 1,195.0% during the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company's stock valued at $35,855,000 after buying an additional 2,096,705 shares during the period. Loomis Sayles & Co. L P raised its holdings in shares of Omada Health by 23.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company's stock valued at $29,283,000 after acquiring an additional 346,588 shares in the last quarter. Divisadero Street Capital Management LP bought a new stake in Omada Health in the third quarter valued at $30,510,000. Finally, Jefferies Financial Group Inc. bought a new stake in shares of Omada Health during the 4th quarter valued at about $16,948,000.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on OMDA shares. Wall Street Zen raised Omada Health from a "hold" rating to a "buy" rating in a report on Saturday, June 27th. BMO Capital Markets dropped their price objective on Omada Health from $27.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, March 6th. Wells Fargo & Company lifted their price target on Omada Health from $17.00 to $18.00 and gave the stock an "equal weight" rating in a research note on Friday, May 8th. Needham & Company LLC reaffirmed a "buy" rating and issued a $28.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Finally, Canaccord Genuity Group set a $24.00 price target on shares of Omada Health in a research note on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $22.91.
Read Our Latest Stock Report on OMDA
About Omada Health
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
